Stroke and Thromboembolism in Atrial Fibrillation: – Systematic Review of Stroke Risk Factors and Risk Stratification Schema –
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
We performed a systematic review of the available evidence on the relationship between the individual clinical, echocardiographic and laboratory characteristics of patients with atrial fibrillation (AF) and the risk of stroke. A systematic review was also performed of all published stroke risk stratification models, as well as the accuracy of their discriminative ability between risk strata. Third, we reviewed the literature on cost-effectiveness analyses with oral anticoagulation in AF. From the systematic review on stroke risk factors, a prior stroke or transient ischemic attack (15/16 studies positive, risk ratio [RR] 2.86), hypertension (11/20 studies positive, RR 2.27), aging (9/13 studies positive, RR 1.46 per decade increase), structural heart disease (9/13 studies positive, RR 2.0) and diabetes (9/14 studies positive, RR 1.62) were found to be good independent predictors of stroke. Supportive evidence was found for sex (8/22 studies positive, RR 1.67), vascular disease (6/17 studies positive, RR 2.61) and heart failure (7/18 studies positive, RR 1.85). The various risk stratification schemes classified variable proportions as low, moderate and high risk, but the CHA(2)DS(2)-VASc score classified the smallest proportion of patients as 'low risk'. Anticoagulation with vitamin K antagonists and dabigatran is cost-effective in patients at high risk of stroke, but not in patients without any other stroke risk factor beside AF. Continued efforts are warranted to improve the antithrombotic management of AF patients to identify, and challenge, risk factors and refine risk stratification models in order to realize an individualized tailored, risk factor-based approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationDeveloped with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationGage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939
Self-citationMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
Self-citationLip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,080
Self-citationA New Risk Scheme to Predict Warfarin-Associated Hemorrhage
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., & Singer, D. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.031 · Cited by 852
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Go, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 703
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., Asinger, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 663
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · Chest · doi:10.1378/chest.126.3_suppl.429s · Cited by 547
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 494
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-1 · Cited by 477
Fang, M. C., Singer, D. E., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Go, A. S. (2005) · Circulation · doi:10.1161/circulationaha.105.553438 · Cited by 469
Go, A. S., Fang, M. C., Udaltsova, N., Chang, Y., Pomernacki, N. K., Borowsky, L., & Singer, D. E. (2009) · Circulation · doi:10.1161/circulationaha.108.816082 · Cited by 450
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00458-5 · Cited by 434
Novo, S., Rubio, J. S., Desideri, A., Mantovani, D., Rossi, D., Lombardi, F., Coppola, G., Garcia, J. A. B., Meloni, M., & Martinez, V. B. (2010) · Default journal · Cited by 434
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Freeman, J. V., Zhu, R. P., Owens, D. K., Garber, A. M., Hutton, D. W., Go, A. S., Wang, P. J., & Turakhia, M. P. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00289 · Cited by 429
Lip, G., Lindhardsen, J., Lane, D., Ahlehoff, O., Hansen, M., Raunsø, J., Tolstrup, J., Hansen, P., Gislason, G., Torp-Pedersen, C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0364 · Cited by 428
Self-citationStroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
Friberg, L., Hammar, N., & Rosenqvist, M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehn599 · Cited by 380
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Self-citationGallagher, A., Setakis, E., Plumb, J., Clemens, A., & van Staa, T.-P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0353 · Cited by 359
Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
Shah, S. V., & Gage, B. F. (2011) · Circulation · doi:10.1161/circulationaha.110.985655 · Cited by 337
Gage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.279.16.1273 · Cited by 315
van Walraven, C., Hart, R. G., Connolly, S., Austin, P. C., Mant, J., Hobbs, F. D. R., Koudstaal, P. J., Petersen, P., Perez-Gomez, F., Knottnerus, J. A., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.526988 · Cited by 312
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0784 · Cited by 301
Self-citationVAN STAA, T. P., SETAKIS, E., DI TANNA, G. L., LANE, D. A., & LIP, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 272
Self-citationFriberg, L., Benson, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · BMJ · doi:10.1136/bmj.e3522 · Cited by 268
Self-citationKirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., Schotten, U., Wegscheider, K., Boriani, G., Brandes, A., et al. (2012) · Europace · doi:10.1093/europace/eur241 · Cited by 243
Self-citationSex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation
Jackevicius, C. A. (2012) · JAMA · doi:10.1001/jama.2012.3490 · Cited by 241
Lip, G. Y. H., & Edwards, S. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.08.007 · Cited by 235
Self-citationHealey, J. S., Hart, R. G., Pogue, J., Pfeffer, M. A., Hohnloser, S. H., De Caterina, R., Flaker, G., Yusuf, S., & Connolly, S. J. (2008) · Stroke · doi:10.1161/strokeaha.107.500199 · Cited by 225
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2007) · QJM · doi:10.1093/qjmed/hcm076 · Cited by 217
Self-citationPink, J., Lane, S., Pirmohamed, M., & Hughes, D. A. (2011) · BMJ · doi:10.1136/bmj.d6333 · Cited by 216
Rietbrock, S., Heeley, E., Plumb, J., & van Staa, T. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.03.010 · Cited by 211
van Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.936 · Cited by 209
Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines, C., Bax, J. J., et al. (2012) · doi:10.48350/15016 · Cited by 206
Self-citationKansal, A., Connolly, S., Peng, S., Linnehan, J., Bradley-Kennedy, C., Plumb, J., & Sorensen, S. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0089 · Cited by 205
Risk for systemic embolization of atrial fibrillation without mitral stenosis
Cabin, H. S., Clubb, K. S., Hall, C., Perlmutter, R. A., & Feinstein, A. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90323-s · Cited by 197
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J.-Y. L., Kay, G. N., Lowe, J. E., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm315 · Cited by 185
Thomson, R., Parkin, D., Eccles, M., Sudlow, M., & Robinson, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90012-6 · Cited by 179
Hirsh, J., Dalen, J. E., & Guyatt, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.1s · Cited by 170
Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation
Stollberger, C., Chnupa, P., Kronik, G., Brainin, M., Finsterer, J., Schneider, B., & Slany, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00004 · Cited by 169
Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
Lee, S., Anglade, M. W., Pham, D., Pisacane, R., Kluger, J., & Coleman, C. I. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.011 · Cited by 139
Risk of thromboembolic events in patients with atrial flutter
Seidl, K., Hauer, B., Schwick, N. G., Zellner, D., Zahn, R., & Senges, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00419-6 · Cited by 135
Lin, L., Lee, C., Yu, C., Tsai, C., Lai, L.-P., Hwang, J., Chen, P., & Lin, J.-L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.033 · Cited by 135
Olesen, J. B., Fauchier, L., Lane, D. A., Taillandier, S., & Lip, G. Y. H. (2011) · CHEST Journal · doi:10.1378/chest.11-0862 · Cited by 133
Self-citationCost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
Kim, H., Kim, H., Cho, S.-K., Kim, J.-B., Joung, B., & Kim, C. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2018.0220 · Cited by 132
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
Moulton, A. W., Singer, D. E., & Haas, J. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90008-l · Cited by 130
Petersen, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.819 · Cited by 129
Gustafsson, C., Asplund, K., Britton, M., Norrving, B., Olsson, B., & Marké, L. A. (1992) · BMJ · doi:10.1136/bmj.305.6867.1457 · Cited by 129
Kansal, A. R., Sorensen, S. V., Gani, R., Robinson, P., Pan, F., Plumb, J. M., & Cowie, M. R. (2012) · Heart · doi:10.1136/heartjnl-2011-300646 · Cited by 127
Pearce, L. A., Hart, R. G., & Halperin, J. L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00440-x · Cited by 110
Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation
Aronow, W. S., Gutstein, H., & Hsieh, F. Y. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90349-4 · Cited by 107
Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Køber, L., Hansen, M. L., Karasoy, D., Hansen, C. M., Gislason, G., & Torp-Pedersen, C. T. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.024 · Cited by 106
Self-citationGorin, L., Nonin, E., Labriolle, A. D., Haguenoer, K., Cosnay, P., Babuty, D., Charbonnier, B., & Fauchier, L. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-10-0746 · Cited by 106
van Latum, J. C., Koudstaal, P. J., Venables, G. S., van Gijn, J., Kappelle, L. J., & Algra, A. (1995) · Stroke · doi:10.1161/01.str.26.5.801 · Cited by 104
Potpara, T. S., Polovina, M. M., Licina, M. M., Marinkovic, J. M., Prostran, M. S., & Lip, G. Y. H. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966713 · Cited by 102
Self-citationMitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation
Nakagami, H., Yamamoto, K., Ikeda, U., Mitsuhashi, T., Goto, T., & Shimada, K. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70231-5 · Cited by 98
Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation
Sorensen, S. V., Dewilde, S., Singer, D. E., Goldhaber, S. Z., Monz, B. U., & Plumb, J. M. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.03.022 · Cited by 88
ABC of Atrial Fibrillation: ANTITHROMBOTIC TREATMENT FOR ATRIAL FIBRILLATION
Lip, G. Y. H., & Lowe, G. D. O. (1996) · BMJ · doi:10.1136/bmj.312.7022.45 · Cited by 77
Self-citationMercaldi, C. J., Ciarametaro, M., Hahn, B., Chalissery, G., Reynolds, M. W., Sander, S. D., Samsa, G. P., & Matchar, D. B. (2011) · Stroke · doi:10.1161/strokeaha.110.592907 · Cited by 76
Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00247-1 · Cited by 74
Lightowlers, S., & McGuire, A. J. (1998) · Stroke · doi:10.1161/01.str.29.9.1827 · Cited by 71
Eckman, M. H., Levine, H. J., Salem, D. N., & Pauker, S. G. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.699s · Cited by 70
Heeringa, J., Conway, D., van der Kuip, D. A. M., Hofman, A., Breteler, M. M. B., Lip, G. Y. H., & Witteman, J. C. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02115.x · Cited by 70
Self-citationWang, T. J., Massaro, J. M., & Levy, D. A. (2003) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.09.035 · Cited by 65
Stöllberger, C., Chnupa, P., Abzieher, C., Länger, T., Finsterer, J., Klem, I., Hartl, E., Wehinger, C., & Schneider, B. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270111 · Cited by 61
Hobbs, R. F., Roalfe, A. K., Lip, G. Y. H., Fletcher, K., Fitzmaurice, D. A., & Mant, J. (2011) · BMJ · doi:10.1136/bmj.d3653 · Cited by 59
Self-citationLangkilde, L. K., Asmussen, M. B., & Overgaard, M. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.673525 · Cited by 54
Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation
Inoue, H., & Atarashi, H. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01105-x · Cited by 52
Waldo, A. L. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79274-5 · Cited by 52
Rasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A. M., Overvad, K., & Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04308.x · Cited by 48
Self-citationLee, S., Anglade, M. W., Meng, J., Hagstrom, K., Kluger, J., & Coleman, C. I. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965251 · Cited by 39
Desbiens, N. A. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50212.x · Cited by 38
Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis
Ruigómez, A., Johansson, S., Wallander, M.-A. A., Edvardsson, N. G., & Rodríguez, L. A. G. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.050 · Cited by 32
Jowett, S. M., Bryan, S., Mant, J., Fletcher, K., Roalfe, A. K., Fitzmaurice, D. A., Lip, G. Y. H., & Hobbs, R. F. (2011) · Stroke · doi:10.1161/strokeaha.110.600767 · Cited by 28
Self-citationAge and Risk of Stroke in Atrial Fibrillation: Evidence for Guidelines?
Frost, L., Andersen, L. V., GODTFREDSEN, J., & Mortensen, L. S. (2007) · Neuroepidemiology · doi:10.1159/000101509 · Cited by 26
van Walraven, C., Hart, R. G., & Wells, G. A. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00311-8 · Cited by 23
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study
ANDERSEN, L. V., Mortensen, L. S., Lip, G. Y. H., Lindholt, J. S., Færgeman, O., Henneberg, E. W., & Frost, L. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04435.x · Cited by 17
Self-citationfor the TIARA pilot study group, Dinh, T., Baur, L. H. B., Pisters, R., Otto Kamp, B., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Tieleman, R. G., Prins, M. H., et al. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0095-3 · Cited by 17
Self-citation
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citationVan Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Self-citationAntithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Self-citationSteinhubl, S. R., Waalen, J., Edwards, A. M., Ariniello, L. M., Mehta, R. R., Ebner, G. S., Carter, C., Baca-Motes, K., Felicione, E., Sarich, T., et al. (2018) · JAMA · doi:10.1001/jama.2018.8102 · Cited by 539
Brundel, B. J. J. M., Ai, X., Hills, M. T., Kuipers, M. F., Lip, G. Y. H., & de Groot, N. M. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00347-9 · Cited by 499
Self-citation
Metadata
- Authors
- Pisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H.
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2012
- Volume
- 76
- Issue
- 10
- Pages
- 2289-2304
- ISSN
- 1346-9843 (ISSN-L)
- 1347-4820
- OpenAlex
- W2028933957
- Cited by
- 159
- References
- 95
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.